SCHEMBL7215867

SCHEMBL7215867

COC(=O)C1=Cc2cc(OCc3ccc(F)cc3F)ccc2CCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.49
GSK3B P49841 2/20 0.46
BACE1 P56817 2/20 0.46
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
FFAR4 Q5NUL3 5/20 0.41
SCN9A Q15858 1/20 0.40
SCN3A Q9NY46 1/20 0.40
PPARA Q07869 1/20 0.40
MMP1 P03956 1/20 0.39
ADAM17 P78536 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
PTGER1 P34995 1/20 0.39
MME P08473 1/20 0.38
ACE P12821 1/20 0.38
CPA1 P15085 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7215895 0.88 MAOB (0.49) MAOBGSK3BBACE1NPC1RAB9A
SCHEMBL7222742 0.86 MAOB (0.52) MAOBNPC1RAB9AL3MBTL1KDM4E
SCHEMBL7221736 0.84 NPC1 (0.44) MAOBNPC1RAB9AL3MBTL1SCN9A
SCHEMBL7222844 0.81 MAPT (0.53) MAOBNPC1RAB9AL3MBTL1KDM4E
SCHEMBL7218045 0.80 MAOB (0.55) MAOBNPC1RAB9AL3MBTL1KDM4E
SCHEMBL7216351 0.79 NPC1 (0.50) MAOBNPC1RAB9AL3MBTL1PPARA
SCHEMBL7221550 0.78 NPC1 (0.45) MAOBNPC1RAB9AL3MBTL1ADAM17
SCHEMBL7218351 0.78 CA12 (0.52) NPC1RAB9AL3MBTL1KDM4EALDH1A1
SCHEMBL7222970 0.77 MAPT (0.52) MAOBNPC1RAB9AL3MBTL1KDM4E
SCHEMBL7216065 0.75 PARP10 (0.47) MAOBNPC1RAB9AL3MBTL1ADAM17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6627651-B1 Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-09-30 US disclosed
EP-1182195-A1 CYCLIC COMPOUNDS AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2002-02-27 EP disclosed